Trademark Overview
On Wednesday, July 3, 2024, a trademark application was filed for TUMOROL with the United States Patent and Trademark Office. The USPTO has given the TUMOROL trademark a serial number of 98632101. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 3, 2024. This trademark is owned by Cannabis Bioscience International Holdings. The TUMOROL trademark is filed in the Pharmaceutical Products category with the following description:
Tumorol is nutraceutical vitamin used in cancer treatment due to its reported antiproliferative, antimetastatic, and antiangiogenic properties. These activities suggest that Tumorol may inhibit the growth of cancer cells (antiproliferative), prevent the spread of cancer to other parts of the body (antimetastatic), and reduce the formation of new blood vessels that tumors need to grow (antiangiogenic).